The ASPP interaction network: Electrostatic differentiation between pro- and anti-apoptotic proteins

Journal of Molecular Recognition

Volumn 24, Issue 2, 2011, Pages 266-274

  Benyamini, Hadar ^a   Friedler, Assaf ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

ASPP; ASPP2; Bcl 2; computational studies; iASPP; interaction network; NF kappa B; p53

Indexed keywords

AMINO ACID; ANKYRIN; APOPTOSIS REGULATORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN BCL 2; PROTEIN P53;

AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM; MOLECULAR GENETICS; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; SEQUENCE ALIGNMENT; STATIC ELECTRICITY; SURFACE PROPERTY; THERMODYNAMICS;

AMINO ACID SEQUENCE; AMINO ACIDS; ANKYRIN REPEAT; APOPTOSIS REGULATORY PROTEINS; BINDING SITES; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2; SEQUENCE ALIGNMENT; STATIC ELECTRICITY; SURFACE PROPERTIES; THERMODYNAMICS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952176416     PISSN: 09523499     EISSN: 10991352     Source Type: Journal    
DOI: 10.1002/jmr.1048     Document Type: Article

References (32)

1. Adams JM, Cory S,. 1998. The Bcl-2 protein family: arbiters of cell survival. Science 281 (5381): 1322-1326. (Pubitemid 28406819)
2. Ahn J, Byeon IJ, Byeon CH, Gronenborn AM,. 2009. Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins. J. Biol. Chem. 284 (20): 13812-13822.
3. Alva V, Devi DP, Sowdhamini R,. 2008. COILCHECK: an interactive server for the analysis of interface regions in coiled coils. Protein Pept. Lett. 15 (1): 33-38. (Pubitemid 351206473)
4. Andrusier N, Nussinov R, Wolfson HJ,. 2007. FireDock: fast interaction refinement in molecular docking. Proteins 69 (1): 139-159. (Pubitemid 47339146)
5. Baldwin AS Jr., 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Ann. Rev. Immunol. 14: 649-683. (Pubitemid 26130197)
6. Basseres DS, Baldwin AS,. 2006. Nuclear factor-kappaB and inhibitor of kappaB kinase pathways in oncogenic initiation and progression. Oncogene 25 (51): 6817-6830. (Pubitemid 44657854)
7. Benyamini H, Leonov H, Rotem S, Katz C, Arkin IT, Friedler A,. 2009. A model for the interaction between NF-kappa-B and ASPP2 suggests an I-kappa-B-like binding mechanism. Proteins 77 (3): 602-611.
8. Bergamaschi D, Samuels Y, O'Neil NJ, Trigiante G, Crook T, Hsieh JK, O'Connor DJ, Zhong S, Campargue I, Tomlinson ML, Kuwabara PE, Lu X,. 2003. iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human. Nat. Genet. 33 (2): 162-167. (Pubitemid 36177067)
9. Camacho CJ, Zhang C,. 2005. FastContact: rapid estimate of contact and binding free energies. Bioinformatics 21 (10): 2534-2536. (Pubitemid 40731617)
10. Cao Y, Hamada T, Matsui T, Date T, Iwabuchi K,. 2004. Hepatitis C virus core protein interacts with p53-binding protein, 53BP2/Bbp/ASPP2, and inhibits p53-mediated apoptosis. Biochem. Biophys. Res. Commun. 315 (4): 788-795. (Pubitemid 38249372)
11. Chothia C,. 1976. The nature of the accessible and buried surfaces in proteins. J. Mol. Biol. 105 (1): 1-12.
12. Delano WL,. 2002. The PyMOL Molecular Graphics System. DeLano Scientific LLC, San Carlos, CA, USA.
13. Dutta J, Fan Y, Gupta N, Fan G, Gelinas C,. 2006. Current insights into the regulation of programmed cell death by NF-kappaB. Oncogene 25 (51): 6800-6816. (Pubitemid 44657853)
14. Espanel X, Sudol M,. 2001. Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains. J. Biol. Chem. 276 (17): 14514-14523.
15. Friedler A, Hansson LO, Veprintsev DB, Freund SM, Rippin TM, Nikolova PV, Proctor MR, Rudiger S, Fersht AR,. 2002. A peptide that binds and stabilizes p53 core domain: chaperone strategy for rescue of oncogenic mutants. Proc. Natl Acad. Sci. U.S.A. 99 (2): 937-942. (Pubitemid 34106614)
16. Gorina S, Pavletich NP,. 1996. Structure of the p53 tumor suppressor bound to the ankyrin and SH3 domains of 53BP2. Science 274 (5289): 1001-1005. (Pubitemid 26398426)
17. Helps NR, Barker HM, Elledge SJ, Cohen PT,. 1995. Protein phosphatase 1 interacts with p53BP2, a protein which binds to the tumour suppressor p53. FEBS Lett. 377 (3): 295-300. (Pubitemid 26025716)
18. Iwabuchi K, Bartel PL, Li B, Marraccino R, Fields S,. 1994. Two cellular proteins that bind to wild-type but not mutant p53. Proc. Natl Acad. Sci. U.S.A. 91 (13): 6098-6102. (Pubitemid 24188290)
19. Katz C, Benyamini H, Rotem S, Lebendiker M, Danieli T, Iosub A, Refaely H, Dines M, Bronner V, Bravman T, Shalev DE, Rüdiger S, Friedler A,. 2008. Molecular basis of the interaction between the antiapoptotic Bcl-2 family proteins and the proapoptotic protein ASPP2. Proc. Natl Acad. Sci. U.S.A. 105 (34): 12277-12282.
20. Kobayashi S, Kajino S, Takahashi N, Kanazawa S, Imai K, Hibi Y, Ohara H, Itoh M, Okamoto T,. 2005. 53BP2 induces apoptosis through the mitochondrial death pathway. Genes Cells 10 (3): 253-260. (Pubitemid 40425937)
21. Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N, Ohara O,. 1998. Prediction of the coding sequences of unidentified human genes. XII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 5 (6): 355-364. (Pubitemid 128670156)
22. Naumovski L, Cleary ML,. 1996. The p53-binding protein 53BP2 also interacts with Bcl2 and impedes cell cycle progression at G2/M. Mol. Cell. Biol. 16 (7): 3884-3892. (Pubitemid 26199908)
23. Patel S, George R, Autore F, Fraternali F, Ladbury JE, Nikolova PV,. 2008. Molecular interactions of ASPP1 and ASPP2 with the p53 protein family and the apoptotic promoters PUMA and Bax. Nucleic Acids Res. 36 (16): 5139-5151.
24. Robinson RA, Lu X, Jones EY, Siebold C,. 2008. Biochemical and Structural Studies of ASPP Proteins Reveal Differential Binding to p53, p63, and p73. Structure 16 (2): 259-268. (Pubitemid 351215211)
25. Rotem S, Katz C, Friedler A,. 2007. Insights into the structure and protein-protein interactions of the pro-apoptotic protein ASPP2. Biochem. Soc. Trans. 35 (Pt 5): 966-969. (Pubitemid 350206406)
26. Rotem S, Katz C, Benyamini H, Lebendiker M, Veprintsev D, Rudiger S, Danieli T, Friedler A,. 2008. The structure and interactions of the proline-rich domain of ASPP2. J. Biol. Chem. 283 (27): 18990-18999.
27. Samuels-Lev Y, O'Connor DJ, Bergamaschi D, Trigiante G, Hsieh JK, Zhong S, Campargue I, Naumovski L, Crook T, Lu X,. 2001. ASPP proteins specifically stimulate the apoptotic function of p53. Mol. Cell. 8 (4): 781-794. (Pubitemid 33030212)
28. Schwede T, Kopp J, Guex N, Peitsch MC,. 2003. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res. 31 (13): 3381-3385. (Pubitemid 37442164)
29. Tidow H, Veprintsev DB, Freund SM, Fersht AR,. 2006. Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53 binding protein 2 (53BP2). J. Biol. Chem. 281 (43): 32526-32533. (Pubitemid 46036807)
30. Vogelstein B, Lane D, Levine AJ,. 2000. Surfing the p53 network. Nature 408 (6810): 307-310.
31. Yang JP, Hori M, Sanda T, Okamoto T,. 1999a. Identification of a novel inhibitor of nuclear factor-kappaB, RelA-associated inhibitor. J. Biol. Chem. 274 (22): 15662-15670.
32. Yang JP, Hori M, Takahashi N, Kawabe T, Kato H, Okamoto T,. 1999b. NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene 18 (37): 5177-5186. (Pubitemid 29460653)